Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Gains from Sales and Divestitures (2018 - 2022)

Inogen (INGN) has disclosed Gains from Sales and Divestitures for 5 consecutive years, with $37678.0 as the latest value for Q3 2022.

  • On a quarterly basis, Gains from Sales and Divestitures fell 60.85% to $37678.0 in Q3 2022 year-over-year; TTM through Sep 2022 was $37678.0, a 60.85% decrease, with the full-year FY2021 number at $15728.0, down 68.31% from a year prior.
  • Gains from Sales and Divestitures was $37678.0 for Q3 2022 at Inogen, roughly flat from $37677.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $96230.0 in Q3 2021 to a low of $4370.0 in Q2 2018.
  • A 5-year average of $26855.2 and a median of $15730.0 in 2019 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: surged 404.71% in 2019, then crashed 68.31% in 2021.
  • Inogen's Gains from Sales and Divestitures stood at $18112.0 in 2018, then fell by 13.14% to $15732.0 in 2019, then surged by 215.51% to $49636.0 in 2020, then plummeted by 68.31% to $15728.0 in 2021, then skyrocketed by 139.56% to $37678.0 in 2022.
  • Per Business Quant, the three most recent readings for INGN's Gains from Sales and Divestitures are $37678.0 (Q3 2022), $37677.0 (Q2 2022), and $5629.0 (Q1 2022).